Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:18 AM
Ignite Modification Date:
2025-12-25 @ 1:18 AM
NCT ID:
NCT01580293
Eligibility Criteria:
Inclusion Criteria:
* Male; 12-65 years of age
* Subjects with severe hemophilia A
* Previously treated with factor VIII for a minimum of 150 exposure days
Exclusion Criteria:
* Inhibitors to FVIII (current evidence or history)
* Any other inherited or acquired bleeding disorder in addition to Hemophilia A
* Platelet count \< 100,000/mm3
* Creatinine \> 2x upper limit of normal or AST/ALT (aspartate aminotransferase/alanine aminotransferase) \> 5x upper limit of normal
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
12 Years
Maximum Age:
65 Years
Study:
NCT01580293
Study Brief:
Protocol Section:
NCT01580293